Stockreport

This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names [Yahoo! Finance]

Definium Therapeutics, Inc. - Common Shares  (DFTX) 
PDF On February 17, 2026, Superstring Capital Management disclosed a new position in Definium Therapeutics (NASDAQ:DFTX) , acquiring 425,202 shares in the fourth quarter. [Read more]